Class information for:
Level 1: TIBOLONE//TIBOLONE METABOLITES//LIVIAL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
21353 363 30.0 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
754 11793 MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TIBOLONE Author keyword 108 44% 52% 187
2 TIBOLONE METABOLITES Author keyword 6 80% 1% 4
3 LIVIAL Author keyword 6 71% 1% 5
4 ORG OD 14 Author keyword 4 75% 1% 3
5 REPROD MED SECT Address 4 75% 1% 3
6 HRT UNIT Address 3 60% 1% 3
7 COMBINED ESTROGEN PLUS PROGESTOGEN THERAPY Author keyword 2 67% 1% 2
8 MAMMOGRAPHIC CHANGES Author keyword 2 67% 1% 2
9 ORG OD14 Author keyword 2 50% 1% 3
10 19 NORTESTOSTERONE DERIVATIVES Author keyword 1 100% 1% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TIBOLONE 108 44% 52% 187 Search TIBOLONE Search TIBOLONE
2 TIBOLONE METABOLITES 6 80% 1% 4 Search TIBOLONE+METABOLITES Search TIBOLONE+METABOLITES
3 LIVIAL 6 71% 1% 5 Search LIVIAL Search LIVIAL
4 ORG OD 14 4 75% 1% 3 Search ORG+OD+14 Search ORG+OD+14
5 COMBINED ESTROGEN PLUS PROGESTOGEN THERAPY 2 67% 1% 2 Search COMBINED+ESTROGEN+PLUS+PROGESTOGEN+THERAPY Search COMBINED+ESTROGEN+PLUS+PROGESTOGEN+THERAPY
6 MAMMOGRAPHIC CHANGES 2 67% 1% 2 Search MAMMOGRAPHIC+CHANGES Search MAMMOGRAPHIC+CHANGES
7 ORG OD14 2 50% 1% 3 Search ORG+OD14 Search ORG+OD14
8 19 NORTESTOSTERONE DERIVATIVES 1 100% 1% 2 Search 19+NORTESTOSTERONE+DERIVATIVES Search 19+NORTESTOSTERONE+DERIVATIVES
9 7 ALPHA METHYL ETHINYL ESTRADIOL 1 100% 1% 2 Search 7+ALPHA+METHYL+ETHINYL+ESTRADIOL Search 7+ALPHA+METHYL+ETHINYL+ESTRADIOL
10 7 ALPHA METHYL ETHINYLESTRADIOL 1 100% 1% 2 Search 7+ALPHA+METHYL+ETHINYLESTRADIOL Search 7+ALPHA+METHYL+ETHINYLESTRADIOL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ORG OD 14 63 77% 12% 43
2 ORG OD14 LIVIALR 20 67% 5% 18
3 ORG OD14 18 67% 4% 16
4 DEPENDENT MCF 7 13 71% 3% 10
5 LIVIALR 9 83% 1% 5
6 PREVIOUS FRACTURES 9 83% 1% 5
7 MAMMOGRAPHIC BREAST DENSITY 5 37% 3% 10
8 POST MENOPAUSAL 4 22% 5% 18
9 T 47D 4 38% 2% 9
10 TIBOLONE TREATMENT 4 75% 1% 3

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Historical milestones in the development of tibolone (Livial (R)) 2011 3 53 85%
Clinical review 140 - Tibolone for postmenopausal women: Systematic review of randomized trials 2002 87 33 76%
Short and long term effects of tibolone in postmenopausal women 2012 2 64 48%
Tibolone: a review 1998 86 39 74%
Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials 2010 10 76 38%
Livial: a review of clinical studies 1999 108 82 48%
The effects of tibolone 1998 35 29 69%
Tibolone and breast cancer 2006 2 41 54%
A review of the effects of tibolone on the skeleton 2004 3 45 56%
What is tibolone - and is it a SPEAR? 2002 2 15 67%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 REPROD MED SECT 4 75% 0.8% 3
2 HRT UNIT 3 60% 0.8% 3
3 GLOBAL VENTURE TEAM LIVIAL 1 100% 0.6% 2
4 COMPARAT MED CLIN 1 11% 2.2% 8
5 BONE METAB SECT 1 33% 0.6% 2
6 CHAUSSEE HULPE 1 50% 0.3% 1
7 DURG METAB KINET 1 50% 0.3% 1
8 ENDOCRINOL GYNECOL PATHOPHYSIOL MENOPAUSE UNIT 1 50% 0.3% 1
9 EQUIPE INSERM ERIT M0101 1 50% 0.3% 1
10 GEN PRACTICE DATABASE GRP 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000198634 ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7
2 0.0000154778 DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST
3 0.0000148753 HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS
4 0.0000126554 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME
5 0.0000120952 MAMMOGRAPHIC DENSITY//BREAST DENSITY//MAMMOGRAPHIC BREAST DENSITY
6 0.0000088576 HOT FLASHES//VASOMOTOR SYMPTOMS//HOT FLUSHES
7 0.0000085971 WOMENS HEALTH INITIATIVE//INTERDISCIPLINARY GRP OSTEOPOROSIS//WHI STUDY
8 0.0000084390 STEROID SULFATASE//ESTRONE SULFATASE//AROMATASE
9 0.0000065300 RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX//BAZEDOXIFENE
10 0.0000060060 COMPREHENS OBES//CELLULAR MOL SPORTS MED//ARKO MOUSE